Filing step-change
PHRMASI · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-20 · Evidence medium
Pharmaxis Limited Sees Accelerating Gross Margin Amid Decelerating Revenue Growth Pharmaxis Limited (PHRMASI) reported a quarterly Gross Margin of 29.09%, accelerating from 3.81%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 29.09 % | 3.81 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 3.81 % | 36.29 | ▼ |
| REVENUE_GROWTH_YOY | 20.5 % | 25 | ▼ |
Cite this
Source: Samhati filing step-change for PHRMASI (2026-10). Observation: Pharmaxis Limited Sees Accelerating Gross Margin Amid Decelerating Revenue Growth Pharmaxis Limited (PHRMASI) reported a quarterly Gross Margin of 29.09%, accelerating from 3.81%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/phrmasi/q/2026-10
Other periods